Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Compass Pathways Plc stock
Learn how to easily invest in Compass Pathways Plc stock.
Compass Pathways Plc (CMPS) is a leading medical care facilities business based in the US. It opened the day at $10.83 after a previous close of $10.72. During the day the price has varied from a low of $10.64 to a high of $10.92. The latest price was $10.70 (25 minute delay). Compass Pathways Plc is listed on the NASDAQ and employs 116 staff. All prices are listed in US Dollars.
How to buy Compass Pathways Plc stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – CMPS. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Compass Pathways Plc stock price (NASDAQ: CMPS)Use our graph to track the performance of CMPS stocks over time.
Compass Pathways Plc shares at a glance
|52-week range||$6.54 - $21.50|
|50-day moving average||$9.50|
|200-day moving average||$11.55|
|Wall St. target price||$44.64|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.94|
Buy Compass Pathways Plc stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Compass Pathways Plc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Compass Pathways Plc price performance over time
|1 week (2023-01-17)||N/A|
|1 month (2022-12-27)||33.58%|
|3 months (2022-10-26)||4.19%|
|6 months (2022-07-26)||-29.61%|
|1 year (2022-01-28)||-27.60%|
|2 years (2021-01-28)||-75.67%|
|3 years (2020-01-24)||N/A|
|5 years (2018-01-24)||N/A|
Compass Pathways Plc financials
|Gross profit TTM||$0|
|Return on assets TTM||-21.71%|
|Return on equity TTM||-34.49%|
|Market capitalisation||$410 million|
TTM: trailing 12 months
Compass Pathways Plc share dividends
We're not expecting Compass Pathways Plc to pay a dividend over the next 12 months.
Compass Pathways Plc share price volatility
Over the last 12 months, Compass Pathways Plc's shares have ranged in value from as little as $6.54 up to $21.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Compass Pathways Plc's is 2.2945. This would suggest that Compass Pathways Plc's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Compass Pathways Plc's beta into context you can compare it against those of similar companies.
Compass Pathways Plc overview
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom. .
Compass Pathways Plc in the news
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023
All You Need to Know About COMPASS Pathways PLC Sponsored ADR (CMPS) Rating Upgrade to Strong Buy
Frequently asked questionsWhat percentage of Compass Pathways Plc is owned by insiders or institutions?
Currently 48.783% of Compass Pathways Plc shares are held by insiders and 18.314% by institutions. How many people work for Compass Pathways Plc?
Latest data suggests 116 work at Compass Pathways Plc. When does the fiscal year end for Compass Pathways Plc?
Compass Pathways Plc's fiscal year ends in December. Where is Compass Pathways Plc based?
Compass Pathways Plc's address is: 33 Broadwick Street, London, United Kingdom, W1F 0DQ What is Compass Pathways Plc's ISIN number?
Compass Pathways Plc's international securities identification number is: US20451W1018
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert